A multicenter randomized controlled clinical trial confirms that both chemical-first and electrical-first approaches are effective strategies for acute atrial fibrillation; however, an ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
Demonstrating one potential application of the technology, an automated algorithm tied to the KardiaBand wearable ECG (AliveCor) performed “reasonably well” at detecting A-fib in patients scheduled ...
Bayer begins phase II study of investigational GIRK4 inhibitor in patients with atrial fibrillation: Berlin Thursday, September 10, 2026, 10:00 Hrs [IST] Bayer announced the initi ...
Pharmacological- and electrical-first cardioversion worked similarly well for treating acute atrial fibrillation (Afib) in the emergency department, according to the Canadian RAFF2 trial. The 204 ...
A newly-designed wristband and corresponding app that works with a smartwatch can accurately display the heart's electrical activity and notify people with atrial fibrillation (AFib) if their heart is ...
If you have atrial fibrillation (AFib), you may not need any treatment, or you may be able to manage it with medication. But this condition is almost always progressive and often needs lifelong ...
Bayer announced today the initiation of a global Phase II clinical trial (NCT07625215) evaluating BAY 3670549, an investigational highly selective G-protein-coupled inwardly rectifying potassium ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results